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are implemented in a manner that benefits the health
system as a whole and builds equity. A programme of ARV
access also has to grapple with the challenge of ensuring
that people take drugs several times a day, every day, for
the rest of their lives. Poor adherence rapidly leads to the
emergence of drug resistance and treatment failure at the
individual level. If resistance develops on a wide scale, this
will have broader public health implications. Obligations on
the part of individuals to adhere have to be matched by
obligations on the part of the health system to ensure
continuous access to uninterrupted supplies of drugs,
skilled providers and laboratory support able to maximise
the safety and efficacy of drugs, and a supportive
environment for adherence. Unfortunately, the margin for
learning through failure is narrow.
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This article reflects the outcomes of aSeminar hosted by
the School of Public Health and Perinatal HIV Researdh
Unit, University of the Witwatersrand, 0!1 Friday 1
August 2003.
SUMMARY OF PROCEEDINGS
Challenges were discussed from all these perspectives
during the course of the seminar, with the purpose of
specifically addressing the health systems challenges. The
seminar deliberately did not address two key aspects of the
scaling up procurement: provision of affordable drugs, and
the mobilisation of financial resources for the
implementation of a programme, as these were being
debated in other fora.
SCAlING UP THE USE OF
ANTIRETROVIRAlS IN THE PUBLIC SECTOR:
WHAT ARE THE CHAlLENGES?
On 1 August 2003 the Wits School of Public Health and
Perinatal HIV Research Unit hosted a l-day seminar on the
challenges to scaling up access to antiretroviral therapy
(ARV or ART) in South Africa.
Highly active antiretroviral therapy (HAART, also referred to
as ART or ARVs) makes a dramatic difference to the survival
and health of people living with HIV. At present only about
1 000 public sector users in South Africa have access to
ARVs through a series of small-scale projects across the
country. Greater access to ARVs could change the lives of
millions of people. It could also bring with it large new
investments in the health system that, if properly planned,
could address systemic weaknesses as well as strengthen
less resourced areas. It is imperative that these investments
The meeting was attended by 130 people, representing a
wide variety of backgrounds and including such diverse
role players as people involved in pilot programmes
successfully delivering antiretrovirals in poor communities
(including a neighbouring country) and those involved in
the roll-out of the mother-to-child transmission
prevention [PMTCT) programme and the national
tuberculosis programme, and the implementation of the
Termination of Pregnancy Act
A number of projects have shown that these challenges can
be confronted on a small scale within the public sector,
such that the benefits of ARVs far outweigh the risks
associated with them. South Africa has a health care
infrastructure that has proved that it is capable of
providing chronic disease care, most notably for
tuberculosis. Scaling up access to ARVs through this system
is not outside the bounds of imagination. However, the TB
programme and the implementation of the Termination of
Pregnancy Act and PMTCT programme provide evidence
highlighting the fact that a programme of universal access
to ARVs will require performance from our health system at
a level and scale far higher than at present. It means
addressing key weaknesses, such as the inadequate staffing
and support of primary health care facilities,
demoralisation and flight of health care workers from the
public sector, inequities in access to facilities, drugs and
other forms of infrastructure, and poor relations between
users, communities and the health system. The experience
from neighbouring Botswana is that the challenges to
scaling up lie in two areas: health system capacity
(particularly human resources) on the one hand, and
stigmatisation and inadequate demand for services on the
other. The need for communication and community
mobilisation emerged as a key theme across all
presentations at the seminar.
Ultimately, to be successful, an ARV programme must face
the complexity of transforming relationships - it must
appreciate its role as one of innovation, of 'thinking out of
the box: It can only do so by mobilising all available
expertise and energies across the country, both inside and
outside government. Given its significance, it is imperative
that all South Africans participate in the process of
discussion and debate about how to implement an ARV
programme.
PROPOSED PRINCIPLES FOR SCALING UP
ACCESS TO ARVs
1. A policy on widespread access to ARVs can only succeed
if it fully mobilises the existing health system. It should
form an integral part of the continuum of HIV care through
the public primary health care and hospital system, co-
ordinated by district, provincial and national management
structures. This does not preclude a degree of
'exceptionalism' and vertical programme arrangements,
under very specific conditions; nor does it exclude the
possibility of co-ordinated action between public and
private sectors where this is deemed relevant at local level.
2. An ARV programme integrated into the health system,
however, will not succeed if it is regarded as a simple 'add-
on' to the multiple functions and activities already
performed by the health system. Additional resources must
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be provided, particularly in the range and numbers of
skilled personnel at facility level, but also in support
systems. New ways of managing existing resources need to
be developed.
3. The massive additional investment in health systems
brought about by an ARV programme provides a unique
opportunity to strengthen the health system as a whole.
Improvements in systems, such as drug supplies, access to
laboratory services, referral, and staff training and support,
should be structured to strengthen quality and access for
all health conditions. An ARV programme should be seen
as an opportunity to address fundamental problems, such
as the public sector human resource crisis and provider
attitudes and values. It should not be implemented at the
cost of other essential health programmes.
4. An ARV programme should not deepen the inequities in
our health system. Ultimately, it must be judged by whether
it succeeds in reaching the most remote and disadvantaged
areas of the country. This may mean special measures to
build the 'capacity to benefit' from an ARV programme in
disadvantaged areas. This would require investment in
basic systems and infrastructure upon which a continuum
of HIV care, including ARVs, can be built.
5. Existing public health and HIV treatment initiatives in
South Africa provide useful models for the design of an
ARV programme. Experiences with the procedures, systems
and infrastructure of the national TB control programme
can inform an ARV programme. They include
standardisation of treatment, registers, monitoring and
evaluation processes and the particular combination of
vertical support and horizontal implementation. Existing
ARV projects suggest that an ARV programme integrated
into a broader HIV care treatment service can be configured
in the same way as other chronic disease programmes, as
nurse-based follow-up with adequate doctor support
6. Alternatives to the main approach to tuberculosis care,
namely 'directly observed therapy', however, are needed if
the stringent adherence requirements of ARVs are to be
achieved. The evidence from pilot projects is that high
levels of adherence stem from a new kind of contract
between providers and clients. This contract is premised on
very high levels of understanding or treatment literacy on
the part of users. It requires the establishment of explicit
support systems for users and community mobilisation and
advocacy processes that promote the rights of people living
with HIV/AIDS. The responsibility for adherence is given to
the client him/herself, but occurs within a clear framework
of empowerment, a period of treatment preparedness and
the building of trusting relationships with providers. This is
very different to the traditional paternalistic and passive
relationship between health care workers and patients, and
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making the change represents the key innovation challenge
of an ARV programme. Central to this relationship are the
front-line providers, who have to be won over to the
purpose, content and process of an ARV programme.
7. How an ARV programme is implemented is as important
as the whotof the programme. To build the levels and scale
of performance required of an ARV programme
necessitates an innovative approach to implementation.
Task teams developing guidelines and procedures at
national level alone will not achieve the rapid buy-in and
change required at all levels of the system. Political
management, in the sense of actively building common
visions, is as important as technical design. We therefore
propose a set of sub-principles to govern the
implementation process:
• The planning process should be as inclusive as possible.
It is important that the voices of all stakeholders with
insight and an interest in the implementation of an ARV
programme be represented in defining the vision and
principles of the programme. These include line and
programme managers at national, provincial and
local/district levels; clinicians and others involved in
pilot ARV programmes or who have shown that they
can provide good quality HIV care in the public sector;
front-line providers, NGOs and activist groupings
involved in community mobilisation; and researchers
who can support monitoring and evaluation. Donors
and external consultants, while clearly important
stakeholders, should not dominate the process. The
roles and responsibilities of all these role players need
to be discussed and agreed upon.
• The process of implementation needs to be supported
by a rigorous and creative communication strategy
aimed at preparing and ensuring the buy-in of all who
will be implicated in the process of implementation. Its
aim would be to develop a common vision and
understanding, as the foundation for action.
• Top-down planning should be combined with bottom-
up processes that harness local energy and stimulate
initiative. The need for defining clear outcomes and
standardisation must be balanced with flexibility in
programme implementation at local level. It also
requires designing an implementation strategy that
involves constant engagement with the periphery in
iterative processes of learning and problem solving, of
learning by doing.
• District and facility actors are much more likely to take
up the challenge of an ARV programme if they can
witness it being done in other districts and by other
actors. Horizontal processes of interaction will lead to
more effective learning tr.an instructions from the top.
A key aspect of implementation must be to promote
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networking between actors already involved in HIV
treatment programmes and those wishing to develop
programmes in their areas.
• An incremental, step-wise process of building capacity
for ARVs needs to be defined. Building blocks such as
the establishment of a good follow-up, 'wellness'
service for people with HIV, evidence of community
mobilisation and support groups, voluntary counselling
and testing and laboratory infrastructure need to be
spelt out Support strategies need to involve not only
training but also mechanisms for developing
infrastructure and systems at facility and district levels.
• While certain aspects of implementation need to be
standardised, local people should be given some choice
and flexibility in the content and pace of
implementation. This includes front-line providers,
users and community members who are the ultimate
implementers of policy. We propose, in the first
instance, a process of voluntary accreditation, in
which facilities and their community and district level
counterparts apply for the right to distribute ARVs. The
onus will rest on them to prove their ability to do so
and will be formally assessed through an accreditation
process where clear criteria are spelt out These districts
could then form learning partnerships with others in
the process of horizontal learning described above.
Obviously, such a process would require co-ordination
and management to ensure that equity is maintained.
• An ARV programme is one necessary and important
component of a wider social response to HIV/AIDS in
South Africa. The HIV epidemic represents both a crisis
and an opportunity for the country - currently in the
midst of profound and dynamic transformation. In this
context, a commitment to scale up the introduction of
ARVs must be viewed alongside a measured and multi-
dimensional approach to HIV - one founded on a
renewed commitment to prevention and to a broader
social response· to the structural conditions that
influenc'e vulnerability to HIV.
FINAL COMMENT
South Africa has the potential to generate a model
approach to the introduction of ARVs that has relevance
and application to the wider sub-Saharan region. As
unprecedented external funds are made available to
support and facilitate this process, effective co-ordination
and providing clear direction around the care components
of the ARV-health systems approach is essential. In this
context, there is a need to balance effective partnerships
and the generation of creative responses on the ground
with a comprehensive vision for the systems required to
sustain such an ambitious intervention in the long term.
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